- Home
- FENC vs EMF Comparison
FENC vs EMF Comparison
Compare FENC & EMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FENC | EMF |
|---|---|---|
| Founded | 1996 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 384.3M | 316.7M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | FENC | EMF |
|---|---|---|
| Price | $10.76 | $22.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 243.7K | 25.2K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.16% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $65.12 | N/A |
| Revenue Next Year | $41.08 | N/A |
| P/E Ratio | $179.67 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $16.07 |
| 52 Week High | $13.25 | $24.70 |
Technical Indicators
Market Signals| Indicator | FENC | EMF |
|---|---|---|
| Relative Strength Index (RSI) | 40.04 | 46.80 |
| Support Level | $9.74 | $21.91 |
| Resistance Level | $11.28 | $22.88 |
| Average True Range (ATR) | 0.58 | 0.45 |
| MACD | -0.24 | -0.09 |
| Stochastic Oscillator | 19.77 | 19.58 |
Price Performance
Historical ComparisonAbout FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company that seeks long-term capital appreciation by investing mainly in emerging country equity securities under normal market conditions. It invests across various sectors, including Pharmaceuticals, Beverages, Broadline Retail, Metals & Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, Insurance, Entertainment, and others.